<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="obo:"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/622eeb38-d5dc-4eba-9fa0-2f11f959e28f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/726bb020-6721-4cb7-bde5-7b787e87543f">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2983d993-2335-4b34-8bdf-330af88ec141"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ed10e1c5-7c9c-49b5-b727-f13f334f47b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/17c46710-e53c-4058-aa1d-7810b2442351">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b0f9680f-b09c-42dd-980a-4f66fbf35429">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fffd8ecb-3541-4caf-a908-1496e7f63ee6"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3275118b-fb34-44a0-8e39-4f584cb4b5ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3fa89768-6b7c-4e1b-9ef2-f555271f6cc2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/622eeb38-d5dc-4eba-9fa0-2f11f959e28f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1244642e-8693-4102-926b-076c67f4994e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000022">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000187">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000221">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ca6fdb71-ec63-410f-ac0a-406709bcb125">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/53cf3760-3f0a-45b4-9097-e86388eddf9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bb9944b7-794b-4011-ae25-b5f5f1f44604">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/81567612-65f5-4117-9f69-cea8d180d314"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b3aafeca-7844-46e5-966a-caa264f34014"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1b9338a3-7ca6-4fb4-954e-027db605d2df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1244642e-8693-4102-926b-076c67f4994e">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8d6ca658-608e-4baf-8bff-219e4b2ea729"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7f423442-ef47-4be9-a1d7-1872545afa3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c003cd94-1c9c-46e2-bcdb-9332842c2f9b">
    <rdf:type rdf:resource="obo:MeSH_D014635"/>
    <rdfs:label>divalproex sodium</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000050">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bd13b90c-d25b-4516-8c8a-521df5e08b52">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
    <rdfs:label>nefazodone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/db62eea3-6725-45ae-b3ea-f3d8ede9760f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e5b7fba5-db4e-4b97-abff-53d4c078b02b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a116271a-a01a-4b60-8df8-7e8a72d3c8c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b3a5509f-e6eb-477e-914c-f7a5a5fd7d59">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/82c59a84-b93c-4e85-866e-0785e827baa7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/959cb61b-74f6-4e53-a4e2-00b3ccba061a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/212ac19a-d895-4c6d-9219-004184024d4c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3001eecf-c065-4e59-ab90-03437a4e438c"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/aa1cd42c-b063-4c11-8270-33d6452b5312">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/91e39034-b50b-4284-94d3-c2da81e8b312">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a116271a-a01a-4b60-8df8-7e8a72d3c8c1">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c5e14cee-e60b-4e0f-903e-f9247a77d7be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/70757561-a374-4eb9-9cb0-051fd5e627dd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/db62eea3-6725-45ae-b3ea-f3d8ede9760f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/17c46710-e53c-4058-aa1d-7810b2442351"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/bd13b90c-d25b-4516-8c8a-521df5e08b52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e070aff0-ca97-468f-86b1-05d01071449f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/55888d8a-af45-48aa-b574-f679f2318427"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d75bb8b8-25e8-4534-a1f3-8cffa3460ad2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b8b8a181-db46-432a-adea-ff071a3dbcd1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/aa7c58f5-9a86-43f4-9d3b-34a940457b7e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3001eecf-c065-4e59-ab90-03437a4e438c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e4bde22a-8586-403a-bd9f-beec1327a101"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/aa7c58f5-9a86-43f4-9d3b-34a940457b7e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/574bf84f-53e2-403e-ae0d-3776caa25acc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fffd8ecb-3541-4caf-a908-1496e7f63ee6"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6281350e-d055-431d-9dd2-9a49be4b4dce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000053">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1b9338a3-7ca6-4fb4-954e-027db605d2df">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/aa1cd42c-b063-4c11-8270-33d6452b5312"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/726bb020-6721-4cb7-bde5-7b787e87543f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8a18ddbf-8a7b-4aa1-834b-8e4f07add297">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0b17c4ec-0e33-470c-892e-9ea4265a414a">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e7284abb-b1ad-4946-be38-aede651b4447"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e7284abb-b1ad-4946-be38-aede651b4447">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b3aafeca-7844-46e5-966a-caa264f34014">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2983d993-2335-4b34-8bdf-330af88ec141">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3275118b-fb34-44a0-8e39-4f584cb4b5ea">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5caf0caf-5e1d-47ba-9c15-6f24c6f642c8"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5caf0caf-5e1d-47ba-9c15-6f24c6f642c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c5e14cee-e60b-4e0f-903e-f9247a77d7be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3e529544-1d53-482a-b9da-f3f4d0edb6d0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e070aff0-ca97-468f-86b1-05d01071449f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7f423442-ef47-4be9-a1d7-1872545afa3f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8581039c-8447-464f-a3cf-d78a091df622">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/55888d8a-af45-48aa-b574-f679f2318427">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
    <rdfs:label>digoxin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e4bde22a-8586-403a-bd9f-beec1327a101">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3fa89768-6b7c-4e1b-9ef2-f555271f6cc2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/30424846-6045-4e48-aae6-4bd8dfaf78ce"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c003cd94-1c9c-46e2-bcdb-9332842c2f9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/835ffb02-ff80-42b0-b358-a21b0058af71">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8a18ddbf-8a7b-4aa1-834b-8e4f07add297"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/959cb61b-74f6-4e53-a4e2-00b3ccba061a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8581039c-8447-464f-a3cf-d78a091df622"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/54518117-7137-445e-af1a-374688750721"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/82c59a84-b93c-4e85-866e-0785e827baa7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8581039c-8447-464f-a3cf-d78a091df622"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/835ffb02-ff80-42b0-b358-a21b0058af71"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e5b7fba5-db4e-4b97-abff-53d4c078b02b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/30424846-6045-4e48-aae6-4bd8dfaf78ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9a6ed19d-2dad-4f25-a032-10620bb682d6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/70757561-a374-4eb9-9cb0-051fd5e627dd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/09cb66a2-76fd-44dc-b757-49743f378121"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/09cb66a2-76fd-44dc-b757-49743f378121">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/212ac19a-d895-4c6d-9219-004184024d4c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bb9944b7-794b-4011-ae25-b5f5f1f44604"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ca6fdb71-ec63-410f-ac0a-406709bcb125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/54518117-7137-445e-af1a-374688750721">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ed10e1c5-7c9c-49b5-b727-f13f334f47b3"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fffd8ecb-3541-4caf-a908-1496e7f63ee6">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b8b8a181-db46-432a-adea-ff071a3dbcd1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/91e39034-b50b-4284-94d3-c2da81e8b312"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0b17c4ec-0e33-470c-892e-9ea4265a414a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d75bb8b8-25e8-4534-a1f3-8cffa3460ad2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8d6ca658-608e-4baf-8bff-219e4b2ea729">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6281350e-d055-431d-9dd2-9a49be4b4dce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/53cf3760-3f0a-45b4-9097-e86388eddf9d"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/81567612-65f5-4117-9f69-cea8d180d314">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
    <rdfs:label>INVEGA</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ee1a519b-46c2-4c50-8dbe-5955b5091532">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b0f9680f-b09c-42dd-980a-4f66fbf35429"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/574bf84f-53e2-403e-ae0d-3776caa25acc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3e529544-1d53-482a-b9da-f3f4d0edb6d0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9a6ed19d-2dad-4f25-a032-10620bb682d6"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
</rdf:RDF>
